Press Releases

Liquidia Announces Presentations at the CHEST 2022 Annual Meeting

MORRISVILLE, N.C. , Oct. 17, 2022 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) (“Liquidia” or the “Company”) today announced the presentation of data related to the investigational use of YUTREPIA™ (treprostinil) inhalation powder, previously referred to as LIQ861, at the CHEST 2022
Oct 17, 2022
Displaying 1 - 10 of 137